Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model

Authors: Yun Wang, Lei Jing, Xiao-Min Zhao, Ji-Ju Han, Zuo-Li Xia, Shu-Cun Qin, Ya-Ping Wu, Xue-Jun Sun

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Hydrogen-rich saline has been reported to have antioxidant and anti-inflammatory effects and effectively protect against organ damage. Oxidative stress and inflammation contribute to the pathogenesis and/or development of pulmonary hypertension. In this study, we investigated the effects of hydrogen-rich saline on the prevention of pulmonary hypertension induced by monocrotaline in a rat model.

Methods

In male Sprague-Dawley rats, pulmonary hypertension was induced by subcutaneous administration of monocrotaline at a concentration of 6 mg/100 g body weight. Hydrogen-rich saline (5 ml/kg) or saline was administred intraperitoneally once daily for 2 or 3 weeks. Severity of pulmonary hypertension was assessed by hemodynamic index and histologic analysis. Malondialdehyde and 8-hydroxy-desoxyguanosine level, and superoxide dismutase activity were measured in the lung tissue and serum. Levels of pro-inflammatory cytokines (tumor necrosis factor-α, interleukin-6) in serum were determined with enzyme-linked immunosorbent assay.

Results

Hydrogen-rich saline treatment improved hemodynamics and reversed right ventricular hypertrophy. It also decreased malondialdehyde and 8-hydroxy-desoxyguanosine levels, and increased superoxide dismutase activity in the lung tissue and serum, accompanied by a decrease in pro-inflammatory cytokines.

Conclusions

These results suggest that hydrogen-rich saline ameliorates the progression of pulmonary hypertension induced by monocrotaline in rats, which may be associated with its antioxidant and anti-inflammatory effects.
Appendix
Available only for authorised users
Literature
1.
go back to reference McLaughlin VV, McGoon MD: Pulmonary arterial hypertension. Circulation. 2006, 114: 1417-1431. 10.1161/CIRCULATIONAHA.104.503540.CrossRefPubMed McLaughlin VV, McGoon MD: Pulmonary arterial hypertension. Circulation. 2006, 114: 1417-1431. 10.1161/CIRCULATIONAHA.104.503540.CrossRefPubMed
2.
go back to reference Crosswhite P, Sun Z: Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens. 2010, 28: 201-212. 10.1097/HJH.0b013e328332bcdb.CrossRefPubMedPubMedCentral Crosswhite P, Sun Z: Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens. 2010, 28: 201-212. 10.1097/HJH.0b013e328332bcdb.CrossRefPubMedPubMedCentral
3.
go back to reference Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM: Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol. 2006, 290: L1069-L1077. 10.1152/ajplung.00408.2005.CrossRefPubMed Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM: Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol. 2006, 290: L1069-L1077. 10.1152/ajplung.00408.2005.CrossRefPubMed
4.
go back to reference Kamezaki F, Tasaki H, Yamashita K, Tsutsui M, Koide S, Nakata S, Tanimoto A, Okazaki M, Sasaguri Y, Adachi T, Otsuji Y: Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med. 2008, 177: 219-226. 10.1164/rccm.200702-264OC.CrossRefPubMed Kamezaki F, Tasaki H, Yamashita K, Tsutsui M, Koide S, Nakata S, Tanimoto A, Okazaki M, Sasaguri Y, Adachi T, Otsuji Y: Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med. 2008, 177: 219-226. 10.1164/rccm.200702-264OC.CrossRefPubMed
5.
go back to reference Redout EM, van der Toorn A, Zuidwijk MJ, van de Kolk CW, van Echteld CJ, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS: Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. Am J Physiol Heart Circ Physiol. 2010, 298: H1038-H1047. 10.1152/ajpheart.00097.2009.CrossRefPubMed Redout EM, van der Toorn A, Zuidwijk MJ, van de Kolk CW, van Echteld CJ, Musters RJ, van Hardeveld C, Paulus WJ, Simonides WS: Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure. Am J Physiol Heart Circ Physiol. 2010, 298: H1038-H1047. 10.1152/ajpheart.00097.2009.CrossRefPubMed
6.
go back to reference Fontanari P, Badier M, Guillot C, Tomei C, Burnet H, Gardette B, Jammes Y: Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive. Eur J Appl Physiol. 2000, 81: 325-328. 10.1007/s004210050050.CrossRefPubMed Fontanari P, Badier M, Guillot C, Tomei C, Burnet H, Gardette B, Jammes Y: Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa Hydra 10 record human dive. Eur J Appl Physiol. 2000, 81: 325-328. 10.1007/s004210050050.CrossRefPubMed
7.
go back to reference Shirahata S, Kabayama S, Nakano M, Miura T, Kusumoto K, Gotoh M, Hayashi H, Otsubo K, Morisawa S, Katakura Y: Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun. 1997, 234: 269-274. 10.1006/bbrc.1997.6622.CrossRefPubMed Shirahata S, Kabayama S, Nakano M, Miura T, Kusumoto K, Gotoh M, Hayashi H, Otsubo K, Morisawa S, Katakura Y: Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochem Biophys Res Commun. 1997, 234: 269-274. 10.1006/bbrc.1997.6622.CrossRefPubMed
8.
go back to reference Ohta S: Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nippon Ronen Igakkai Zasshi. 2008, 45: 355-362.PubMed Ohta S: Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nippon Ronen Igakkai Zasshi. 2008, 45: 355-362.PubMed
9.
go back to reference Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R: Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008, 441: 167-172. 10.1016/j.neulet.2008.05.077.CrossRefPubMed Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun X, Xu W, Tao H, Li R: Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neurosci Lett. 2008, 441: 167-172. 10.1016/j.neulet.2008.05.077.CrossRefPubMed
10.
go back to reference Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, Jiang L, Sun XJ: Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2009, 381: 602-605. 10.1016/j.bbrc.2009.02.105.CrossRefPubMed Mao YF, Zheng XF, Cai JM, You XM, Deng XM, Zhang JH, Jiang L, Sun XJ: Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochem Biophys Res Commun. 2009, 381: 602-605. 10.1016/j.bbrc.2009.02.105.CrossRefPubMed
11.
go back to reference Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, Makino S, Ohta S, Ogawa S, Fukuda K: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008, 373: 30-35. 10.1016/j.bbrc.2008.05.165.CrossRefPubMed Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, Makino S, Ohta S, Ogawa S, Fukuda K: Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun. 2008, 373: 30-35. 10.1016/j.bbrc.2008.05.165.CrossRefPubMed
12.
go back to reference Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007, 361: 670-674. 10.1016/j.bbrc.2007.07.088.CrossRefPubMed Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun. 2007, 361: 670-674. 10.1016/j.bbrc.2007.07.088.CrossRefPubMed
13.
go back to reference Chen H, Sun YP, Li Y, Liu WW, Xiang HG, Fan LY, Sun Q, Xu XY, Cai JM, Ruan CP, Su N, Yan RL, Sun XJ, Wang Q: Hydrogen-rich saline ameliorates the severity of l-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun. 2010, 393: 308-313. 10.1016/j.bbrc.2010.02.005.CrossRefPubMed Chen H, Sun YP, Li Y, Liu WW, Xiang HG, Fan LY, Sun Q, Xu XY, Cai JM, Ruan CP, Su N, Yan RL, Sun XJ, Wang Q: Hydrogen-rich saline ameliorates the severity of l-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun. 2010, 393: 308-313. 10.1016/j.bbrc.2010.02.005.CrossRefPubMed
14.
go back to reference Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, Luo X, Sun X: Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 23: 129-137. 10.1016/j.brainres.2008.11.048.CrossRef Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, Luo X, Sun X: Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2009, 23: 129-137. 10.1016/j.brainres.2008.11.048.CrossRef
15.
go back to reference Pichardo J, Palace V, Farahmand F, Singal PK: Myocardial oxidative stress changes during compensated right heart failure in rats. Mol Cell Biochem. 1999, 196: 51-57. 10.1023/A:1006914111957.CrossRefPubMed Pichardo J, Palace V, Farahmand F, Singal PK: Myocardial oxidative stress changes during compensated right heart failure in rats. Mol Cell Biochem. 1999, 196: 51-57. 10.1023/A:1006914111957.CrossRefPubMed
16.
go back to reference Sun B, Liu WL: The method to measure pulmonary artery pressure in pulmonary hypertension model. Acta Academiae Medicinae Sinicae. 1984, 6: 465-PubMed Sun B, Liu WL: The method to measure pulmonary artery pressure in pulmonary hypertension model. Acta Academiae Medicinae Sinicae. 1984, 6: 465-PubMed
17.
go back to reference Abe K, Shimokawa H, Morikawa K, watoku TU, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A: Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res. 2004, 94: 385-393. 10.1161/01.RES.0000111804.34509.94.CrossRefPubMed Abe K, Shimokawa H, Morikawa K, watoku TU, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A: Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res. 2004, 94: 385-393. 10.1161/01.RES.0000111804.34509.94.CrossRefPubMed
18.
go back to reference Handoko ML, Schalij I, Kramer K, Sebkhi A, Postmus PE, Van Der Laarse WJ, Paulus WJ, Vonk-Noordegraaf A: A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research. Pflügers Arch. 2008, 455: 951-959.CrossRefPubMed Handoko ML, Schalij I, Kramer K, Sebkhi A, Postmus PE, Van Der Laarse WJ, Paulus WJ, Vonk-Noordegraaf A: A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research. Pflügers Arch. 2008, 455: 951-959.CrossRefPubMed
19.
go back to reference Rosenberg HC, Rabinovitch M: Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988, 255: H1484-H1491.PubMed Rosenberg HC, Rabinovitch M: Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988, 255: H1484-H1491.PubMed
20.
go back to reference Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM: Primary pulmonary hypertension between inflammation and cancer. Chest. 1998, 114 (Suppl 3): 225-230. 10.1378/chest.114.3_Supplement.225S.CrossRef Voelkel NF, Cool C, Lee SD, Wright L, Geraci MW, Tuder RM: Primary pulmonary hypertension between inflammation and cancer. Chest. 1998, 114 (Suppl 3): 225-230. 10.1378/chest.114.3_Supplement.225S.CrossRef
21.
go back to reference Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF: Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med. 2004, 169: 764-769. 10.1164/rccm.200301-147OC.CrossRefPubMed Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF: Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med. 2004, 169: 764-769. 10.1164/rccm.200301-147OC.CrossRefPubMed
22.
go back to reference Au WW, Oberheitmann B, Harms C: Assessing DNA damage and health risk using biomarkers. Mut Res. 2002, 509: 153-163. 10.1016/S0027-5107(02)00226-9.CrossRef Au WW, Oberheitmann B, Harms C: Assessing DNA damage and health risk using biomarkers. Mut Res. 2002, 509: 153-163. 10.1016/S0027-5107(02)00226-9.CrossRef
Metadata
Title
Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model
Authors
Yun Wang
Lei Jing
Xiao-Min Zhao
Ji-Ju Han
Zuo-Li Xia
Shu-Cun Qin
Ya-Ping Wu
Xue-Jun Sun
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-26

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.